510(k) Report

510(k) · Cleared

Cleared

Spotlight Access System

K112913510(k) SpecialCleared Dec 16, 201174-day reviewClass II21 CFR 882.4800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Johnson & Johnson · GZT Retractor, Self-Retaining, For Neurosurgery

Cleared on Dec 16, 2011 as substantially equivalent to K062814 (Depuy Spine, Inc., 2006) and 1 other predicate after a 74-day review. Its family tree reaches back 2 generations to 1999.

Decided
Dec 16, 2011
Review
74 days
Class
Class II
Product code
GZT
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K992898 (1999). No later device cites it as a predicate yet.

  1. Root · 2 generations backK992898 The Bright Medical Dilation Retractor SystemBright Medical Instruments · 1999
  2. 1 generation backK062814 Pipeline II Access SystemDepuy Spine, Inc. · 2006
  3. This deviceK112913 Spotlight Access SystemJohnson & Johnson · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K992898The Bright Medical Dilation Retractor SystemBright Medical Instruments1999—
−1K062814Pipeline II Access SystemDepuy Spine, Inc.2006—
0 (this device)K112913Spotlight Access SystemJohnson & Johnson2011—
FIG. 1 — Lineage of K112913, 1999–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZT device

  1. #1 K252995 Durashield Device Kitscore 12.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062814Pipeline II Access System
Summary page 1
…osurgery per 21 CFR § 882.4800 D. Predicate Device Name Trade name: De~uy Spine, Inc. SPOTLIGH'FM Access System (K0628 14) Bright Medical Dilation Retractor System (K(992898) E. Device Description The SP…
Depuy Spine, Inc.2006—
*K992898The Bright Medical Dilation Retractor System
Summary page 1
…Predicate Device Name Trade name: De~uy Spine, Inc. SPOTLIGH'FM Access System (K0628 14) Bright Medical Dilation Retractor System (K(992898) E. Device Description The SPOTLIGFm Access System consists of a series of dilators…
Bright Medical Instruments1999—

Also cleared against K062814: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 7.2 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K062814.

How does its category compare?

All GZT devices

GZT Retractor, Self-Retaining, For Neurosurgery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GZT

1in 2022

2007: 22009: 12010: 12011: 12012: 22015: 12016: 12017: 32018: 12020: 12021: 12022: 12026 (partial year): 1
2007high 3 (2017) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZT

280in 2017

2017: 280 days median
2007high 280 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZT

1in 2012

2007: 12012: 1, 1 Class I
2007high 1 (2007) · low 0 (2008)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GZT

1in 2025

2009: 12010: 42011: 42012: 62013: 122014: 162015: 42016: 52017: 92018: 32019: 52020: 32021: 22022: 42023: 22024: 82025: 1
2007high 16 (2014) · low 0 (2007)2025

MAUDE reports naming product code GZT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—10
20080—00
20091—01
20101—04
20111—04
20122—1 (1)6
20130—012
20140—016
20151—04
20161—05
2017328009
20181—03
20190—05
20201—03
20211—02
20221—04
20230—02
20240—08
20250—01
20261—0—

What is it indicated for?

The SPOTLIGHT Access System is intended to provide the surgeon with minimally invasive surgical access to the spine by ensuring the placement/positioning of the port, down to the posterior and posterolateral bony spinal elements. These ports provide access to the spinal site which can be visualized using a microscope or loupes, and through which surgical instruments can be manipulated.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112913: Spotlight Access System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K112913

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026